Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

Yes, Leo alluded to oral Brilacidin forumulations for treatment of inflammatory bowel disease.

From Dr. Bertolino on 03/16:

“We’re getting exactly what we need from a proof-of-concept study—clear and strong signals both as to the safety and the efficacy of Brilacidin in treating IBD. These results will help guide the continued development of Brilacidin, including planned foam and oral formulations, for hard-to-treat chronic conditions like Ulcerative Colitis and Crohn’s Disease.”

From Leo on 03/21:

“With planned newer formulations, foam and oral, we believe Brilacidin could one day be extended into treating a number of chronic IBD indications.

"